+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Skin Rash Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Skin Rash Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 384 Pages
  • Global
From
Lung Cancer Drugs Market Report 2026 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Global Biosimilars Market 2020-2025 - Product Thumbnail Image

Global Biosimilars Market 2020-2025

  • Report
  • May 2021
  • 358 Pages
  • Global
From
Acute Myeloid Leukemia Market Report 2026 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Leukemia Therapeutics Market Report 2026 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Multiple Myeloma Drugs Market Report 2026 - Product Thumbnail Image

Multiple Myeloma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Myelodysplastic Syndrome Market Report 2026 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
Gonorrhea Therapeutics - Global Strategic Business Report 2026 - Product Thumbnail Image

Gonorrhea Therapeutics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 140 Pages
  • Global
From
Loading Indicator